Search
HamburgerClose
news

Dow Microbial Control and Strategic Partners, Inc., Collaborate to Bring Next Generation Medical Scrubs to Market

5 May 2015

Philadelphia, PA - May 05, 2015 - Dow Microbial Control, a business unit of The Dow Chemical Company (NYSE:DOW), and Strategic Partners, Inc., (SPI), the leading designer, manufacturer and distributor of comfortable, functional and fashionable medical apparel and lab wear in the U.S., are collaborating to develop the next generation of medical scrubs and lab coats. The new product offerings will feature SILVADUR™ Antimicrobial, a breakthrough Dow product that helps reduce, inhibit and minimize the buildup of bacteria on apparel, which can cause odors and affect garment life and fit.

“In our view, the best possible way to meet their needs and give them greater peace of mind was for Dow, a recognized marketplace leader in antimicrobial technology, to work closely with SPI, the leader in producing and marketing garments worn by medical professionals.”
Karel Williams, global strategic marketing associate director

“Market research clearly shows that healthcare professionals have a growing concern about bacteria on their clothing and value medical scrubs and lab coats with antimicrobial protection,” says Karel Williams, global strategic marketing associate director, Dow Microbial Control. “In our view, the best possible way to meet their needs and give them greater peace of mind was for Dow, a recognized marketplace leader in antimicrobial technology, to work closely with SPI, the leader in producing and marketing garments worn by medical professionals.”

Business management and technical teams from Dow Microbial Control and SPI have extensively tested the performance of scrubs and lab coats treated with SILVADUR™, according to Williams. Third-party evaluations of more than 300 fabric samples validated SILVADUR's™ ability to meet or exceed SPI's high standards for efficacy against a broad spectrum of bacteria; durability; effects on the feel, finish and appearance of fabrics; impact on the environment and other criteria.

“We are excited to lead a new era of healthcare apparel with Dow's proven antimicrobial technology as part of SPI's new CERTAINTY™ technology brand,” says Mike Singer, chief executive officer of SPI. With uniform distributors across the U.S., the nation's healthcare professionals will have access to our new Code Happy™ brand, Infinity™ by Cherokee® collection and Dickies® and Cherokee professional lab wear that will appeal to their sense of style, comfort and function.”

SILVADUR™ Antimicrobial has consistently gained share in a range of apparel and textile markets since its introduction in the fall of 2012 because it answers the pressing marketplace need for an efficient and effective antimicrobial. Among SILVADUR's™ features that distinguish it from traditional microbial control systems is a patented, “intelligent” microbial control mechanism that reduces the cost to treat apparel, while providing long-lasting performance. In September 2013, R&D Magazine recognized SILVADUR™ as one of the 100 most technologically significant products introduced over a 12-month period.

About Strategic Partners, Inc.

Established in 1995, Strategic Partners, Inc. designs, manufactures and distributes high-quality, fashion-inspired medical uniforms under the Cherokee, Dickies, HeartSoul, Code Happy, Infinity and Disney brands; manufactures and/or distributes footwear under the Cherokee, Dickies, Asics and K-Swiss brands, among many others; and manufactures and distributes medical accessories and Classroom brand school uniforms. The company supports nurses and other healthcare professionals through Scrubs Magazine, a leading lifestyle media brand for nurses, and its website, scrubsmag.com, the nation's number-one online destination for nurses; and numerous outreach and philanthropic activities. The corporation's home office is in Chatsworth, California. Visit www.strategicpartners.net.